Squalene is a triterpenoid hydrocarbon that was first isolated from shark liver oil and was named by Tsujimoto in 1916 (1) . More recently this compound has been found to be widely distributed in biological materials. Squalene has been identified and studied in-plant oils and leaves (2, 3) , in fungi (4), in tobacco and cigarette smoke (5) , and in fish oils (6, 7) . A small concentration of squalene with a rapid turnover has been identified in rat liver (8) . Larger concentrations have been found in human sebum-like materials, including sebum (9) (10) (11) (12) , ear wax (9, 11) , hair fat (13) , smegma (9) , dermoid cyst fat (11, 14) , and vernix caseosa (15) .
Squalene is now well established as the biosynthetic intermediate immediately preceding the formation of the sterol nucleus. During the course of sterol biosynthesis squalene undergoes direct cyclization to lanosterol, which is then converted to cholesterol (16) (17) (18) (19) (20) . Recent studies have also defined the reaction sequence between mevalonic acid and squalene (21) (22) (23) and have partly defined the unusual reaction mechanism involved in squalene biosynthesis from its immediate precursor, farnesyl pyrophosphate (24) (25) (26) . The position of squalene in the biosynthetic pathway to cholesterol is indicated in Figure 1 .
In the present study, small concentrations of metabolically active squalene have been identified in human and rat blood plasma.
Methods
Forty microcuries of DL-2-C"-mevalonic acid, in solution in isotonic saline, was injected intravenously into a fasting normal young adult man. Serial blood samples were collected in syringes moistened with a solution of * Submitted for publication November heparin and were immediately placed on ice. The samples were centrifuged at 2,000 X g for 45 minutes at 40 C, and the plasma was removed. Small samples of plasma were extracted immediately. Larger volumes of plasma (28 to 38 ml per sample) were used for the serial separation of lipoprotein classes as described by Havel, Eder, and Bragdon (27) The thiourea adduct of squalene was prepared, and the squalene later regenerated, as described by Goodman and Popjik (23) . Carrier pure squalene l was added before preparation of the adduct.
Thin-layer chromatography (TLC) of squalene was carried out on thin layers of silica gel G using benzene: hexane, 3: 97, as ascending solvent. The plates were impregnated with rhodamine 6G to permit ready visualization under ultraviolet light. After chromatography of carrier squalene the plates showed a single narrow squalene band of Rf approximately 0.5, with several very faint bands of greater R5. TLC of sterols was performed as described by Avigan, Goodman, and Steinberg (29), using benzene: ethyl acetate, 5:1. Carrier lanosterol-dihydrolanosterol 2 was added to the free sterol samples of biological origin before chromatography. The developed plates showed widely separated bands of lanosterol-dihydrolanosterol (Rf ca. 0.75) and cholesterol (Rf ca. 0.6). Elution of various portions of the plates was accomplished by scraping the desired zone on to a filter funnel and eluting with CHCIL. Table I is consistent with the conclusion that the radioactivity in the hydrocarbon fraction resided in a compound on the biosynthetic pathway from C14-nevalonic acid to cholesterol. The only known compound on this pathway that appears in the hydrocarbon fraction after silicic acid chromatography is squalene. Further chromatographic identification of the hydrocarbon radioactivity was attempted by TLC. Portions of the 1.8-and the 4.8-hour hydrocarbon samples from the very low density lipoproteins were chromatographed, together with 1 mg carrier squalene, as described above. With each sample, the narrow squalene band was scraped from the plate and eluted. The entire remainder of the plate, from the origin to the solvent front, was also scraped and eluted. Assay of the eluates for C14 showed that, for the two samples, respectively, 83 and 86% of the recovered radioactivity were found in the squalene zone.
Carrier squalene (20 dig) was added to a portion of the 2.9-hour hydrocarbon sample, and the thiourea adduct formed. The squalene regenerated from the adduct contained 77% of the expected radioactivity.
Rat. Silicic acid column chromatography of the lipid samples from rat plasma revealed the presence of considerable radioactivity in the hydrocarbon fraction of the early sample (A) but very little in the hydrocarbon fraction of the later sample (B). The results are presented in Table  II . As with the human subject, most of the hydrocarbon radioactivity was found associated with the very low density lipoprotein.
Carrier squalene (50 Mtg) was added to portions of the hydrocarbon fractions from each of the lipoprotein fractions of plasma sample A and from the very low density lipoprotein fraction of plasma sample B. After formation of the thiourea adduct and regeneration of the squalene, more than 90% of the radioactivity was recovered, in each sample, in the regenerated squalene.
Gas chromatographic estimation of squalene concentration. Portions of the very low density lipoprotein hydrocarbon fractions from the 2.9-hour sample of the human subject and from rat sample A, were saponified and the nonsaponifiables analyzed by GLC. Similar results were obtained with both the human and rat samples. Both samples showed a single major peak with retention time identical to that of pure squalene. This peak was preceded by a series of much smaller peaks and followed by only one definite very small peak (retention time, 1.36 X squalene). No further peaks emerged during a total chromatography time of 85 minutes. The identities of the small peaks with retention times other than that of squalene are not known; these peaks may represent impurities accumulated during the processing of the samples, or they may represent unknown compounds of biological origin present in the original lipoprotein samples.
An estimate was made of the squalene concentration in plasma by assuming that the gas chromatographic peak with retention time identical to that of squalene represented squalene derived from the lipoprotein sample. The area of this peak was then compared to the areas observed with known amounts of pure squalene, on GLC under identical conditions. This provided an estimate of squalene mass, which could be related to the volume of plasma from which this squalene was derived. These calculations indicated that the concentration of squalene in the very low density lipoprotein fraction was approximately 29 ,ug per 100 ml human plasma and approximately 36 pg per 100 ml rat plasma.
Lanosterol. Preliminary evidence was also obtained for the presence of lanosterol in plasma. Portions of the free sterol fractions of human and rat plasma were chromatographed together with carrier lanosterol as described under Methods. The developed plates were scraped and eluted in three zones: lanosterol, an intermediate zone between lanosterol and cholesterol, and cholesterol. This procedure is identical with that employed in the study of the time course of cholesterol biosynthesis in rat liver (20) . As discussed elsewhere (20) the lanosterol TLC zone should contain 30-carbon sterols, the intermediate zone 28 -and 29-carbon sterols, and the cholesterol zone 27-carbon sterols. The results obtained in the present study are presented in Table III . In the rat plasma and rat liver samples, the early sample (A) showed significant radioactivity in both the lanosterol and intermediate TLC zones. The later (B) samples showed significantly less radioactivity in these zones. The amounts of radioactivity found in the lanosterol and intermediate zones in the A samples were much greater than the technical error of the chromatographic procedure. Previous studies have indicated that such lanosterol zone radioactivity from liver nonsaponifiables actually resides in C14-lanosterol and that the intermediate zone radioactivity from liver probably resides in 28-carbon sterols (20) . It is thus reasonable to presume that the lanosterol and intermediate zone radioactivity found in plasma also resided in corresponding sterol precursors of cholesterol. The time course of the distribution of radioactivity shown in Table III is consistent with this hypothesis.
Relatively less radioactivity was found in the lanosterol and intermediate TLC zones with the human plasma samples. The relative amount of radioactivity in these TLC zones was, however, greatest in the earliest plasma sample and decreased progressively with time (see Table III ). This time course suggests that, as with the rat plasma, the lanosterol and intermediate zone radioactivity actually resided in sterol precursors of cholesterol present in human plasma. Analysis of the three lipoprotein fractions from the 2.9-hour sample (Table III early peaks and a small peak with retention time corresponding to that of cholesterol. There were no peaks discernible at retention times corresponding to lanosterol or dihydrolanosterol, or at retention times that might be expected for 28-or 29-carbon sterols. The sensitivity of the instrument was such that approximately 0.5 ug of either lanosterol or dihydrolanosterol should have been definitely detected. By relating the GLC sample size to the corresponding volume of plasma, it was possible to estimate that the concentration of free lanosterol in plasma, if present, must be less than 40 jpg per 100 ml in man and less than 35 ug per 100 ml in the rat.
Discussion
The data presented here demonstrate the presence of small amounts of metabolically active squalene in human and rat plasma. Radioactivity rapidly appeared in, and then subsequently disappeared from, this squalene pool after intravenous C14-mevalonate. Identification of the radioactivity as residing in squalene included its chromatographic behavior on silicic acid columns and thin-layer plates and its formation, with carrier squalene, of a thiourea adduct. These properties provide a fairly confident, albeit inferential, identification. There is no known metabolite of mevalonic acid other than squalene that would exhibit this combination of properties. Most of the labeled plasma squalene was found associated with the very low density (< 1.019) lipoprotein fraction in both man and the rat. The concentration of squalene in the plasma very low density lipoprotein was estimated by gas-liquid chromatography to be approximately 30 to 35 pg squalene per 100 ml plasma in both species.
The rapid appearance and disappearance of radioactivity in plasma squalene indicated that this squalene was in close equilibrium with the tissue squalene pool involved in cholesterol biosynthesis from C14-mevalonate. This tissue pool was undoubtedly located in the liver, which is the major organ involved in cholesterol biosynthesis. Langdon and Bloch (8) have estimated that the concentration of squalene in rat liver is of the order of 25 pg per g of tissue. Although this is probably a maximal estimate [see (8) ], it does indicate that the squalene pool in plasma is much smaller than the liver pool with which it is apparently in close equilibrium.
Preliminary data have also been presented that suggest the presence of small amounts of lanosterol and of other sterol precursors of cholesterol in plasma. These sterols were apparently also in close equilibrium with their corresponding liver pools. The concentration of free lanosterol, if present, was less than 35 jug per 100 ml plasma.
Summary
Radioactive squalene has been observed transiently in human and rat plasma after the intravenous administration of C14-mevalonic acid. Identification of the labeled squalene included its chromatographic behavior and its formation of a thiourea adduct. Most of the labeled squalene was associated with the very low density (density < 1.019) lipoprotein fraction, in which its concentration was estimated to be approximately 30 to 35 fig per 100 ml plasma in both species. The plasma squalene pool appears to be in close equilibrium with the larger liver squalene pool.
Preliminary evidence has also been obtained that suggests the presence of small amounts of lanosterol in plasma.
